23.8.2007

New Company Headquarters

BIA Separations GesmbH Austria was established by a group of international investors with the aim of providing novel and cutting edge technologies for the analysis, separation and purification of drug substances and molecules for therapeutic/diagnostic use. To pursue this goal, the company first needed to acquire the “monolith technology” of BIA Separations Slovenia by purchasing 100% of its shares.

BIA Separations Austria is committed to continued development of monolith technology to ensure that the biotechnology industry can implement more efficient technologies for the analysis and purification of plasmid DNA, virus particles, and proteins.

If you are interested in joining this growing and dynamic company, please see our Careers section.

Back